A detailed history of Cloud Capital Management, LLC transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Cloud Capital Management, LLC holds 2 shares of KYMR stock, worth $129. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Holding current value
$129
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 03, 2025

BUY
$37.68 - $58.5 $75 - $117
2 New
2 $0

Others Institutions Holding KYMR

About Kymera Therapeutics, Inc.


  • Ticker KYMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 54,705,800
  • Market Cap $3.55B
  • Description
  • Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...
More about KYMR
Track This Portfolio

Track Cloud Capital Management, LLC Portfolio

Follow Cloud Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cloud Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cloud Capital Management, LLC with notifications on news.